Endosense Raises $36 Million

Endosense, a Geneva, Switzerland-based med-tech company focused on improving the efficacy, safety and reproducibility of catheter ablation for the treatment of cardiac arrhythmias, has raised $36 million in Series B funding. Edmond de Rothschild Investment Partners led the round, and was joined by Neomed, GIMV, VI Partners, Sectoral Asset Management, Ysios Capital Partners and Initiative Capital Romandie.

North AmericaUSBriefs